Measurable residual disease and clonal evolution in acute myeloid leukemia from diagnosis to post-transplant follow-up: the role of next-generation sequencing

HIGHLIGHTS

• who: Alessandra Sperotto and collaborators from the Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy have published the paper: Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing, in the Journal: Biomedicines 2023, 359 of /2023/
• what: The aim of the review is to provide an overview of the role of next-generation sequencing in monitoring both measurable residual disease and clonal evolution in acute myeloid . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.